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Objective: to assess quality of life (QOL) in patients with intermittent claudication.
Design: a prospective, open study.
Material and method: one hundred and fifty-one consecutive claudicants (100 men, 51 women), and 161 healthy
controls (70 men and 91 women) completed an adapted version of the World Health Organisation Quality of Life
Assessment Instrument-100.
Results: patients scored significantly worse on the domains Physical health and Level of independence, as well as on the
facets Pain and discomfort, Energy and fatigue, Mobility, Activities of daily living, Dependence on medication and
treatments, Working capacity, Negative feelings, Recreation and leisure and Overall QOL and general health. Increasing
disease to incapacitating claudication affected only the facet Mobility and the domain Level of independence.
Conclusion: QOL in patients with intermittent claudication is reduced in many aspects. Where co-morbidity seems to
affect QOL strongly, the effect of walking distance on QOL might be small. These findings may justify a reserved attitude
towards invasive, even minimally invasive treatment of these patients.
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Introduction concept, comprising the personal evaluation of func-
tioning with regard to physical health, psychological
The severity of intermittent claudication is usually as- state, levelof independence,socialrelationships,personal
beliefs and relationships to salient features in the en-sessed by means of treadmill walking distance or ankle
brachial pressure index (ABPI).1 However, neither of vironment. QOL assesses functioning in relation to the
patients’ own criteria.these variables correlate well with patient reported func-
tional impairment.2–4 An alternative means of assessing The aim of this present study was to measure QOL in
claudicants using the World Health Organisation (WHO)disability is therefore required.
Quality of life (QOL) is increasingly recognised as an instrument.
importantmeasureofdiseaseimpactandtherapeuticout-
come in patients with vascular disease.8,9 However, the
interpretation and comparison of QOL studies is
hampered by the range of different instruments used.10–13 Materials and Methods
In the literature, QOL is often used as a comprehensive
concept: i.e. concepts like functional status and health Patients
status are labelled as QOL. However, functional status
refers to physical functioning; for instance, walking dis- Between January 1999 and 31 December 1999 QOL was
assessed in 151 consecutive patients (100 men, 51 women,tance in claudicants. Health status assesses the influence
of disease on physical, social and emotional functioning: mean age 63 years, range 43–83 years) presenting with
intermittent claudication. The diagnosis was based onit measures restrictions in functioning. QOL as defined
by the World Health Organisation (WHO) is a broader history, physical examination, treadmill-walking dis-
tance and ankle pressure. Impairment was recorded as:
mild, 26 patients; moderate, 72 patients; severe, 53
∗ Please address all correspondence to: J. C. Breek, Department of patients.14 Risk factors and co-morbidity are presented inSurgery, Martini Hospital, PO Box 30033, 9700 RM Groningen, The
Netherlands. Table 1.
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Table 1. Distribution of risk-factors and co-morbidity, specified into ‘‘none’’, ‘‘mild’’, ‘‘mod-
erate’’ and ‘‘severe’’, according to the SVS/ISCVS14 in 151 patients with intermittent clau-
dication, studied for QOL.
None Mild Moderate Severe
Diabetes mellitus 127 (84%) 9 (6%) 11 (7%) 4 (3%)
Tobacco use 27 (18%) 27 (18%) 52 (34%) 45 (30%)
Hypertension 82 (54%) 41 (27%) 20 (13%) 8 (5%)
Hyperlipidaemia 77 (51%) 28 (19%) 15 (10%) 31 (21%)
Cardiac status 99 (66%) 35 (23%) 16 (11%) 1 (1%)
Carotid disease 124 (82%) 8 (5%) 14 (9%) 5 (3%)
Renal status 146 (97%) 3 (2%) 1 (1%) 1 (1%)
Pulmonary status 135 (89%) 9 (6%) 6 (4%) 1 (1%)
Measure facets in the WHOQOL-100 and thus the number of ana-
lyses examined, a probability value of less than 0.01 was
QOL was assessed using the World Health Organisation considered to be statistically significant. The statistical
differences between the three categories of intermittentQuality of Life Assessment Instrument-100 (WHOQOL-
100).15 This is a generic, multidimensional, self-report claudication were analysed with the Kruskal–Wallis test.
The internal consistency of the facets and domains ofQOL measure that is easy to score.16 It has been used in a
wide variety of patient populations,17,18 most recently in the WHOQOL-100, which indicates that the responses to
corresponding questions are comparable, were cal-sarcoidosis.19,20 The instrument has been developed sim-
ultaneously and cross-culturally in 15 centres around the culated with Cronbach’s alpha, a measure of homo-
geneity.22 For the test-re-test reliability of the WHOQOL-world.21 It consists of 100 items assessing 24 facets of QOL
within six domains (Physical health, Psychological 100 facets and domains, Pearson correlations were used.
health, Level of independence, Social relationships, En-
vironment, Spirituality/religion/personal beliefs) and a
Resultsgeneric evaluative facet (Overall QOL and General
health). Each facet is represented by four items. The re-
Compared with healthy people, patients scored worse onsponses are expressed in 5-point scales. Scores on each
several domains (Table 2).facet and domain can range from 4 to 20. The reliability
There were no statistically significant differences in theand validity of the instrument are high,18 also in healthy
distribution of risk factors and co-morbidity between theelderly.17
three categories of intermittent claudication. The threeIn a preceding pilot-study the instrument was reduced
categories (mild, moderate and severe claudication) werefor vascular patients to 17 relevant facets, including Over-
comparable with regard to QOL, except for the facet Mo-all QOL and general health. The patients completed the
bility and the domain Level of independence (Table 3).questionnaire and a research assistant was available for
On the domain level Cronbach’s alpha ranged fromhelp, if needed. The QOL scores of the examined patient
0.62 to 0.82 and on the facet level from 0.67 to 0.93, in-population was put into perspective by comparing them
dicatinganacceptable internalconsistency(Table4).Test–with an age-matched, community-based sample of 161
retest correlations are not very high, but acceptable. In ahealthy persons, without co-morbidity (70 men, 91
random sample with a smaller interval, test-retest re-women, mean age 62 years, range 40–91 years) from the
liability of the WHOQOL-100 at facet level ranged fromvalidation study of the Dutch version of the WHOQOL-
0.55 for Working capacity to 0.87 for Financial resources100.16
and at domain level from 0.72 for Level of independenceAll data were collected by one research assistant.
to 0.86 for Physical health.17
Although the responsiveness of the WHOQOL-100 to
discriminate between sick and healthy people has proven
to be good,18 some facets might be less sensitive in a par-Statistics
ticular group of claudicants. We think that this is the case
for all instruments assessing health status and QOL. TheData are expressed as mean and standard deviation. In
order to detect statistically significant differences be- WHOQOL is a rather new instrument and only future
studies will learn whether the instrument is sensitive intween patients and healthy people, data were analysed
with the Mann–Whitney U-test. Due to the number of these patients or not.
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Table 2. Scores on the reduced WHOQOL-100 in 151 patients with intermittent claudication.
Healthy Patients
m SD m SD U-value Significance
Overall QOL and general health 16 2 14 3 6839.0 p<0.001
Physical health 16 2 13 3 5719.0 p<0.001
Pain and discomfort 9 3 12 3 5004.0 p<0.001
Energy and fatigue 15 3 12 3 5601.0 p<0.001
Sleep and rest 16 3 15 4 ns
Psychological health — —
Positive feelings 14 2 14 2 ns
Thinking, learning, memory
and concentration — —
Self-esteem 15 2 15 3 ns
Body image and appearance — —
Negative feelings 9 3 10 3 9220.0 p<0.005
Level of independence 17 2 13 3 2528.5 p<0.001
Mobility 17 3 11 3 1989.0 p<0.001
Activities of daily living 17 2 14 3 5070.0 p<0.001
Dependence on medication
and treatments 7 3 11 4 3304.5 p<0.001
Working capacity 17 3 13 4 5187.0 p<0.001
Social relationships 16 2 15 3 ns
Personal relationships 16 2 17 3 ns
Social support — —
Sexual activity 15 4 14 4 ns
Environment — —
Physical safety and security — —
Home environment 16 2 16 3 ns
Financial resources — —
Health and social care — —
Opportunities for acquiring
new information and skills 15 2 15 3 ns
Participation in and opportunities
for recreation/leisure 16 3 15 3 9709.0 p=0.01
Physical environment — —
Transport 17 3 16 4 ns
Spirituality, religion, personal
beliefs — —
m: mean.
SD: standard deviation.
ns: not significant.
The scores on the facets Pain and discomfort, Negative feelings and Dependence on medication and treatments are inverse. High scores,
low QOL.
Table 3. Scores on the domain Level of independence and the facet Mobility of the WHOQOL-100 according to the grade of intermittent
claudication in 151 patients.
m SD m SD Significance
Facet mobility
Mild claudication 13 3 compared with Moderate 12 3 ns
Severe 10 2 p<0.001
Moderate claudication 12 3 compared with Severe 10 2 p<0.001
Domain Level of independence
Mild claudication 14 2 compared with Moderate 13 3 ns
Severe 12 2 p=0.025
Moderate claudication 13 3 compared with Severe 12 2 ns
m: mean.
SD: standard deviation.
ns: not significant.
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Table 4. Internal consistency and test–retest correlations (interval six months) of the reduced WHOQOL.
Cronbach’s alpha Pearson correlation
Overall QOL and general health 0.82 0.71
Physical health 0.64 0.73
Pain and discomfort 0.71 0.54
Energy and fatigue 0.80 0.67
Sleep and rest 0.93 0.74
Psychological health — —
Positive feelings 0.74 0.57
Thinking, learning, memory — —
Self-esteem 0.79 0.65
Body image and appearance — —
Negative feelings 0.82 0.60
Level of independence 0.82 0.67
Mobility 0.80 0.38
Activities of daily living 0.82 0.56
Dependence on medication and treatment 0.78 0.64
Working capacity 0.91 0.70
Social relationships 0.62 0.70
Personal relationships 0.67 0.63
Social support — —
Sexual activity 0.81 0.70
Environment — —
Physical safety — —
Home environment 0.79 0.57
Financial resources — —
Health and social care — —
Opportunities for acquiring new information and skills 0.72 0.42
Participation in and opportunities for recreation/leisure 0.77 0.66
Physical environment — —
Transport 0.87 0.51
Spirituality, religion, personal beliefs — —
Discussion status in patients suffering from intermittent clau-
dication. Pell,23 Currie24 and Chetter,25,26 using the Short
The present study highlights the personal and sub- Form-36, the Euroqol and the Nottingham Health Pro-
files, found that patients were impaired in their phys-jective evaluation of functioning in patients suffering
from intermittent claudication. As we reduced the ical, psychological and social functioning, deteriorating
with the grade of claudication. This was especially theWHOQOL-100, bymeans ofparameters fordistribution
of answers and internal consistency, the remaining case in multi-level disease. The explicit Negative feel-
ings as reported by the patients in this study did notquestions are supposed to reflect those facets of life that
are of particular importance to these patients. emerge from the health status studies, because health
status measures do not evaluate subjective feelings ofAnalogous to the health status studies, it appears that
peripheral arterial occlusive disease (PAOD), even in its patients. We feel that disregarding subjective feelings
of patients is one of the important disadvantages ofmildest expression, has a detrimental effect on QOL
as experienced by the patient, compared with healthy merely assessing health status in chronically ill patients,
especially when treatment is mainly palliative.persons. The main difference is found in the facets and
domains evaluating physical functioning, as might be Surprisingly, the three categories of claudicants dif-
fered only significantly with regard to Mobility. In ad-expected in these physically impaired patients. The sig-
nificantly greater Dependence on medication and treat- dition, the patients with the mildest and the patients
with the most severe form of claudication differed onments in claudicants as expressed in the results is not
directly related to an impaired walking distance and the domain Level of independence. With regard to the
other domains and facets of QOL the categories weresuggests an impact of co-morbidity on QOL. This is
not surprising, since patients suffering from PAOD are comparable. This means that with increasing disease
to incapacitating claudication patients’ QOL onlyknown to be affected with important co-morbidity.
There are several reports in the literature on health deteriorates on these two aspects. The grade of
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3 Perkins JMT, Collin J, Creasy TS, Fletcher EWL, Morris PJ.claudication does not seem to be related to the level of
Exercise training versus angioplasty for stable claudication. LongQOL other than Mobility and Level of independence. and medium term results of a prospective randomised trial. Eur J
Vasc Surg 1996; 11: 409–413.Apparently the presence of intermittent claudication,
4 Chetter IC, Dolan P, Spark JI, Scott DJA, Kester RC. Cor-irrespective of the severity, is enough to create a sig-
relating clinical indicators of lower-limb ischaemia with qualitynificant difference on the various domains and facets of of life. Cardiovasc Surg 1997; 5: 361–366.
5 Fraser SCA. Quality of life measurement in surgical practice. BrQOL compared with the healthy population.
J Surg 1993; 80: 163–169.It is important to realise that the scores on QOL as
6 Velanovic V. Using quality-of-life instruments to assess surgicalpresented in this study are the result of all influences outcomes. Surgery 1999; 126: 1–4.
7 Chetter IC, Scott DJA, Kester RC. An introduction to qualityof PAOD and co-morbidity. The relative impact of co-
of life analysis: The new outcome measure in vascular surgery.morbidity in addition to the impaired walking distance
Eur J Vasc Endovasc Surg 1998; 15: 4–6.on QOL has not yet been elucidated. The observation 8 Bergner DK. Measurement of health status. Med Care 1985; 23:
696–704.that increasing claudication only affects Mobility and
9 Stoker MJ, Dunbar GC, Beaumont G. The SmithKline BeechamLevel of independence suggests that successful treat-
‘‘quality of life’’ scale: A validation and reliability study in patientsment in terms of improving the walking distance may with affective disorder. Quality Life Res 1992; 1: 385–395.
10 Ware JE, Sherbourne CD. The SF-36 Short Form health statushave a very limited effect on QOL on the whole.
survey 1, conceptual framework and item selection. Med Care 1992;Although not proven yet, it seems that co-morbidity
30: 473–483.may have a dominant effect on the QOL of patients 11 Hunt SM, McEwen J, McKenna SP. Measuring health status: a
new tool for clinicians and epidemiologists. J R Coll Gen Prac 1985;suffering from intermittent claudication, whereas the
35: 185–188.impaired walking distance might be no more than the
12 The Euroqol group. Euroqol: a new facility for measurement ofexpression of a more complex underlying disease. health related quality of life. Health Policy 1990; 16: 199–208.
13 WHOQOL group (1995). The World Health Organization QualityWe think that the importance of walking distance as
of Life assessment (WHOQOL): Position paper from the Worldthe principal factor in the assessment of patients with
Health Organisation. Soc Sci Med 1995; 41: 1403–1409.intermittent claudication should be questioned. More- 14 Rutherford RB, Baker JD, Ernst C et al. Recommended stand-
ards for reports dealing with lower extremity ischemia: Revisedover, in our opinion the importance of co-morbidity is
version. J Vasc Surg 1997; 26: 517–538.generally underestimated in the literature. That is why
15 De Vries J, Van Heck GL. Nederlandse WHOQOL-100 [Dutchwe feel that invasive therapy, even minimally invasive, WHOQOL-100]. Tilburg: Tilburg University; 1995.
16 WHOQOL group. The WHOQOL assessment. (WHOQOL: De-is questionable in patients with intermittent clau-
velopmentandgeneric psychometricproperties).SocSci Med1998;dication and serious co-morbidity. Future studies
46: 1569–1585.should determine the influence of all factors affecting 17 De Vries J. Beyond health status: Construction and validation of
the Dutch WHO Quality of Life assessment instrument. Thesis.QOL in patients with intermittent claudication, as it
Tilburg: Tilburg University, 1996.seems to depend on more than walking a few hundred
18 De Vries J, Van Heck GL. The World Health Organisation Qualitymetres more or less. of Life assessment instrument (WHOQOL-100): Validation study
with the Dutch version. Eur J Psychol Assessment 1997; 13: 164–178.QOL and health status are considered com-
19 De Vries J, Drent M, Van Heck GL, Wouters EFM. Quality ofplementary concepts27 and should be assessed together
life in sarcoidosis: A comparison between members of a patientin order to evaluate the impact of PAOD on the life of organisation and a random sample. Sarcoidosis Vasc Diffuse Lung
Dis 1998; 15: 183–188.patients with intermittent claudication. Since this is the
20 Wirnsberger RM, De Vries J, Brteler MHM et al. Evaluation offirst study to evaluate QOL in patients with intermittent
quality of life of sarcoidosis patients. Resp Med 1998; 92: 750–756.claudication with a true QOL questionnaire, further 21 WHOQOL group (1994). Development of the WHOQOL: Ra-
tionale and current status. Int J Ment Health 1994; 23: 24–56.study is necessary to determine the complementary
22 Cronbach L. Coefficient alpha and the internal structure of tests.value of QOL on health status in these patients.
Psychometrika 1951; 16: 297–334.
23 Pell JP et al. Impact of Intermittent claudication on quality of life.
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